Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Higher rate of major depression among blood donor candidates infected with human t-cell lymphotropic virus type 1.

Stumpf BP, Carneiro-Proietti AB, Proietti FA, Rocha FL; Interdisciplinary HTLV Research Group.

Int J Psychiatry Med. 2008;38(3):345-55.

PMID:
19069577
2.

Major depression and generalized anxiety disorder among human T-lymphotropic virus types I- and II-infected former blood donors.

Guiltinan AM, Kaidarova Z, Behan D, Marosi C, Hutching S, Kaiser M, Moore E, Devita D, Murphy EL; HTLV Outcomes Study (HOST).

Transfusion. 2013 Jan;53(1):60-8. doi: 10.1111/j.1537-2995.2012.03677.x. Epub 2012 May 3.

3.

Prevalence and risk factors for Human T-Lymphotropic Virus Type 1 (HTLV-1) among maintenance hemodialysis patients.

Santos RF, Conceição GC, Martins MS, Kraychete A, Penalva MA, Carvalho EM, Lopes AA, Rocha PN.

BMC Nephrol. 2017 Feb 15;18(1):64. doi: 10.1186/s12882-017-0484-y.

4.

Urinary symptoms associated with human T-cell lymphotropic virus type I infection: evidence of urinary manifestations in large group of HTLV-I carriers.

Castro NM, Rodrigues W Jr, Freitas DM, Muniz A, Oliveira P, Carvalho EM.

Urology. 2007 May;69(5):813-8.

PMID:
17482910
5.

Higher prevalence of fibromyalgia in patients infected with human T cell lymphotropic virus type I.

Cruz BA, Catalan-Soares B, Proietti F.

J Rheumatol. 2006 Nov;33(11):2300-3.

PMID:
17086610
6.

Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.

Segurado AA, Malaque CM, Sumita LM, Pannuti CS, Lal RB.

Am J Trop Med Hyg. 1997 Aug;57(2):142-8.

PMID:
9288805
7.

Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors--United States, 2000-2009.

Chang YB, Kaidarova Z, Hindes D, Bravo M, Kiely N, Kamel H, Dubay D, Hoose B, Murphy EL.

J Infect Dis. 2014 Feb 15;209(4):523-31. doi: 10.1093/infdis/jit497. Epub 2013 Sep 24.

8.

Human T-lymphotropic virus type 1 and type 2 seroprevalence, incidence, and residual transfusion risk among blood donors in Brazil during 2007-2009.

Carneiro-Proietti AB, Sabino EC, Leão S, Salles NA, Loureiro P, Sarr M, Wright D, Busch M, Proietti FA, Murphy EL; NHLBI Retrovirus Epidemiology Donor Study-II (Reds-II), International Component.

AIDS Res Hum Retroviruses. 2012 Oct;28(10):1265-72. Epub 2012 May 3.

9.
10.

HTLV-I/II and blood donors: determinants associated with seropositivity in a low risk population.

Soares BC, Proietti AB, Proietti FA; Interdisciplinary HTLV-I/II Research Group.

Rev Saude Publica. 2003 Aug;37(4):470-6. Epub 2003 Aug 20.

11.

Human T-cell lymphotropic virus type 1 infection and ocular manifestations in São Paulo, Brazil.

Yamamoto JH, Segurado AA, Hirata CE, Sampaio MW, Souza EC, Nukui Y, Cliquet M, Saéz-Alquézar A, Olivalves E, Mochizuki M.

Arch Ophthalmol. 1999 Apr;117(4):513-7.

PMID:
10206580
12.

[Human T-cell lymphotropic virus in family members of seropositive blood donors: silent dissemination].

Catalan-Soares B, Carneiro-Proietti AB, Proietti FA; Grupo Interdisciplinar de Pesquisas em HTLV.

Rev Panam Salud Publica. 2004 Dec;16(6):387-94. Portuguese.

PMID:
15682520
13.

A high prevalence of human T-lymphotropic virus type I carriers in patients with antithyroid antibodies.

Mizokami T, Okamura K, Ikenoue H, Sato K, Kuroda T, Maeda Y, Fujishima M.

Thyroid. 1994 Winter;4(4):415-9.

PMID:
7711504
14.

Human T-Lymphotropic Virus Type I (HTLV-1) Infection among Iranian Blood Donors: First Case-Control Study on the Risk Factors.

Hedayati-Moghaddam MR, Tehranian F, Bayati M.

Viruses. 2015 Nov 4;7(11):5736-45. doi: 10.3390/v7112904.

15.

Tuberculosis incidence in a cohort of individuals infected with human T-lymphotropic virus type 1 (HTLV-1) in Salvador, Brazil.

Grassi MF, Dos Santos NP, Lírio M, Kritski AL, Chagas Almeida Mda C, Santana LP, Lázaro N, Dias J, Netto EM, Galvão-Castro B.

BMC Infect Dis. 2016 Sep 19;16:491. doi: 10.1186/s12879-016-1428-z.

16.

Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion.

Murphy EL, Lee TH, Chafets D, Nass CC, Wang B, Loughlin K, Smith D; HTLV Outcomes Study Investigators.

J Infect Dis. 2004 Aug 1;190(3):504-10. Epub 2004 Jul 6.

PMID:
15243924
17.

Serological, epidemiological, and molecular differences between human T-cell lymphotropic virus Type 1 (HTLV-1)-seropositive healthy carriers and persons with HTLV-I Gag indeterminate Western blot patterns from the Caribbean.

Rouet F, Meertens L, Courouble G, Herrmann-Storck C, Pabingui R, Chancerel B, Abid A, Strobel M, Mauclere P, Gessain A.

J Clin Microbiol. 2001 Apr;39(4):1247-53.

18.

Impact of depression on quality of life in people living with human T cell lymphotropic virus type 1 (HTLV-1) in Salvador, Brazil.

Galvão-Castro AV, Boa-Sorte N, Kruschewsky RA, Grassi MF, Galvão-Castro B.

Qual Life Res. 2012 Nov;21(9):1545-50. doi: 10.1007/s11136-011-0066-6. Epub 2011 Nov 23.

PMID:
22109110
19.

Deep Sequencing Analysis of Human T Cell Lymphotropic Virus Type 1 Long Terminal Repeat 5' Region from Patients with Tropical Spastic Paraparesis/Human T Cell Lymphotropic Virus Type 1-Associated Myelopathy and Asymptomatic Carriers.

Rego FF, de Oliveira T, Giovanetti M, Galvão-Castro B, Gonçalves Mde S, Alcantara LC.

AIDS Res Hum Retroviruses. 2016 Mar;32(3):279-83. doi: 10.1089/AID.2015.0273. Epub 2015 Nov 10.

PMID:
26472535
20.

Monitoring the HTLV-1 proviral load in the peripheral blood of asymptomatic carriers and patients with HTLV-associated myelopathy/tropical spastic paraparesis from a Brazilian cohort: ROC curve analysis to establish the threshold for risk disease.

Furtado Mdos S, Andrade RG, Romanelli LC, Ribeiro MA, Ribas JG, Torres EB, Barbosa-Stancioli EF, Proietti AB, Martins ML.

J Med Virol. 2012 Apr;84(4):664-71. doi: 10.1002/jmv.23227.

PMID:
22337307

Supplemental Content

Support Center